Investment Summary

Eight Roads Invests In Alternative Bio

On December 15, 2022, private equity firm Eight Roads invested in life science company Alternative Bio

Investment Highlights
  • This is Eight Roads’ 73rd transaction in the Life Science sector.
  • This is Eight Roads’ 4th transaction in Singapore.

Investment Summary

Date 2022-12-15
Target Alternative Bio
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target

Alternative Bio

Singapore, Singapore
Alternative Bio is a biotechnology company developing novel therapeutics targeting a previously untapped class of post-translational modifying enzymes. Alternative Bio is based in Singapore.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 297 of 298
Sector (Life Science) 73 of 74
Type (Venture) 268 of 269
Country (Singapore) 4 of 4
Year (2022) 24 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-27 Elucidata

Cambridge, Massachusetts, United States

Elucidata is a life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. Elucidata was founded in 2015 and is based in Cambridge, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-24 Adcentrx Therapeutics

San Diego, California, United States

Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. Adcentrx Therapeutics was founded in 2021 and is based in San Diego, California.

Buy -